
Sign up to save your podcasts
Or


We discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD with Dr. Mark Barakat, Assistant Clinical Professor of Ophthalmology, University of Arizona School of Medicine-Phoenix.
By Retina Synthesis4.5
88 ratings
We discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD with Dr. Mark Barakat, Assistant Clinical Professor of Ophthalmology, University of Arizona School of Medicine-Phoenix.

18 Listeners

2,445 Listeners

112,683 Listeners

670 Listeners

56,469 Listeners

595 Listeners

4 Listeners

11 Listeners

52 Listeners

10 Listeners

18 Listeners

1 Listeners

0 Listeners

708 Listeners